Topical Therapy for Fungal Infections

@article{Kyle2004TopicalTF,
  title={Topical Therapy for Fungal Infections},
  author={Amber Kyle and Mark V. Dahl},
  journal={American Journal of Clinical Dermatology},
  year={2004},
  volume={5},
  pages={443-451}
}
Fungi often infect the skin surface and subsequently invade the stratum corneum to avoid being shed from the skin surface by desquamation. Pharmacologic agents applied to the surface of the skin in the form of creams, lotions, or sprays, readily penetrate into the stratum corneum to kill the fungi (fungicidal agents), or at least render them unable to grow or divide (fungistatic agents). Thus, topical therapies work well to rid the skin of topical fungi and yeasts. Azole drugs such as… Expand
Topical delivery of antifungal agents
TLDR
A physicochemical and pharmacokinetic guided approach can help to tailor-make therapeutically effective systems for existing antifungal agents, thus doing away with the need for newer agents, which will save on time, money and manpower. Expand
Stability and Efficacy of Anti-dermatophyte Creams From Extract of Kigelia africana Leaves
TLDR
Kigelia africana ethanol extract can be used in herbal cream formulations for the management of dermatophytosis and animal studies evaluation of the ethanolic formulations of the cream indicated that their efficacy against the dermatophytes is concentration dependent. Expand
Antimicrobial Microneedle Patch for Treating Deep Cutaneous Fungal Infection
TLDR
It is demonstrated that MN patches encapsulated with antifungal agent amphotericin B offer outstanding treatment effectiveness, attributable to the high bioavailability of therapeutics and synergistic actions of the antIFungal polymer and drug. Expand
Vesicular nanocarrier based treatment of skin fungal infections: Potential and emerging trends in nanoscale pharmacotherapy
TLDR
The utility of various vesicular nanocarrier systems to treat skin fungal infections is discussed about about bioavailability enhancement of bioactives, high skin permeation power, no side effects at application site, dosing frequency reduction, and sustained drug release. Expand
Nanoethosomes for Topical Fungal Therapeutics
TLDR
The chapter provides an insight into the occurrence and therapy approaches of fungal infection, usefulness of topical therapy, nanoethosomes and its variants, and their applications in the delivery of antifungal agents. Expand
Sertaconazole: a review of its use in the management of superficial mycoses in dermatology and gynaecology.
TLDR
Sertaconazole is a well established antifungal agent, which is now available in a variety of formulations, and remains a useful treatment option particularly in patients with fungal infections resistant to other azoles. Expand
The Susceptibility of Dermatophytes to Photodynamic Treatment with Special Focus on Trichophyton rubrum
TLDR
If the promising in vitro and ex vivo results could be transferred to clinical practice, then PDT has a good prospect to become a worthy alternative to established antifungal drugs. Expand
Antifungal peptides: a potential new class of antifungals for treating vulvovaginal candidiasis caused by fluconazole‐resistant Candida albicans
TLDR
A head‐to‐head comparison of 61 short linear AMPs from the literature was conducted to identify the peptide with the most potent activity against fluconazole‐resistant C. albicans, and the 11‐residue peptide, P11‐6, was identified and assayed against a panel of clinical C.Albicans isolates to gauge its potential for further drug development. Expand
In vitro Antifungal Activity of Camel ’ s Urine against Dermatophytes
Background: Dermatophytes are fungi capable of invading keratinized tissues of humans and animals, causing dermatomycosis. Azoles antifungal drugs are often used in the treatment of dermatomycosis;Expand
Dissolving microneedle patches loaded with amphotericin B microparticles for localised and sustained intradermal delivery: Potential for enhanced treatment of cutaneous fungal infections.
TLDR
This work establishes a novel, easy and effective method for long-acting and localised intradermal drug delivery of Amphotericin B through dissolving microneedle patches loaded with micronised particles of AmB for treatment of cutaneous fungal infections. Expand
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 39 REFERENCES
Immunological resistance to dermatophyte infections.
  • M. Dahl
  • Medicine
  • Advances in dermatology
  • 1987
TLDR
Cell-mediated immune reactions appear to be the major host defense against invasion and appropriate cell-mediated immunity not only can limit the spread of dermatophytic fungi but also can rid the fungus from host skin. Expand
Terbinafine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in superficial mycoses.
TLDR
Although further research is required to establish the efficacy of terbinafine in comparison with other available therapies, as well as to fully clarify its tolerability profile, the early results obtained with terbINAfine in superficial fungal infections are very encouraging. Expand
Amorolfine. A review of its pharmacological properties and therapeutic potential in the treatment of onychomycosis and other superficial fungal infections.
TLDR
Evidence to date does not clarify whether the use of adjuvant topical amorolfine reduces the need for systemic therapy in patients with severely infected nails, or whether amor Adolfine is beneficial in individuals unresponsive to other treatment options. Expand
Dermatopharmacology of ciclopirox nail lacquer topical solution 8% in the treatment of onychomycosis.
  • M. Bohn, K. Kraemer
  • Biology, Medicine
  • Journal of the American Academy of Dermatology
  • 2000
TLDR
Ciclopirox nail lacquer 8% is a topical product that provides an active fungicidal agent in a delivery system capable of penetrating nails and very low levels of ciclipirox are recoverable systemically, even after chronic use. Expand
The use of 40% urea cream in the treatment of moccasin tinea pedis.
TLDR
Evaluated the efficacy of 40% urea cream as an adjunct to topical antifungals in the treatment of moccasin tinea pedis and found a 100% cure rate in 12 patients treated with topical 40% Urea cream and ciclopirox cream concomitantly. Expand
Chronic dermatophytosis: what is special about Trichophyton rubrum?
TLDR
T. rubrum is especially suited to survive on the skin surface, and the mannan may be a more potent immunosuppressor than are mannans from other dermatophytes, and its ability to infect and its ubiquitous presence account for the high incidence of infections. Expand
The antifungal agent butenafine manifests anti-inflammatory activity in vivo.
TLDR
The benzylamine antifungal agent butenafine demonstrates inherent anti-inflammatory properties, in vivo, as demonstrated by reduced cutaneous erythema response after UVB irradiation. Expand
Oral Terbinafine: A New Antifungal Agent
TLDR
Terbinafine is more effective than the gold standard, griseofulvin, in the treatment of tinea pedis and tinea unguinum, with considerably shorter treatment duration in the latter, and may be a front-line drug for some superficial infections responding poorly to the current standard of therapy. Expand
Molecular basis of resistance to azole antifungals.
TLDR
The adaptative changes in fungi, in particular Candida albicans, in response to inhibitors of ergosterol biosynthesis are reviewed to help in devising more effective antifungal therapies. Expand
Acquired immunity to dermatophytes.
TLDR
Experimental dermatophyte ( Trichophyton mentagrophytes ) infections were initiated by using quantified spore inoculi on the forearms of 13 healthy volunteers who manifested no evidence of prior infection, and cell-mediated immunity correlated with this enhanced resistance. Expand
...
1
2
3
4
...